Volume 23, Issue 3 pp. 375-383
ORIGINAL ARTICLE

Impact of body mass index on short-term and long-term survival in prevalent hemodialysis patients

Muhittin Ertilav

Muhittin Ertilav

Division of Nephrology, Abant Izzet Baysal University School of Medicine, Bolu, Turkey

Search for more papers by this author
W. Nathan Levin

W. Nathan Levin

Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, USA

Search for more papers by this author
Aygul Celtik

Aygul Celtik

Division of Nephrology, Ege University School of Medicine, Izmir, Turkey

Search for more papers by this author
Fatih Kircelli

Fatih Kircelli

Medical Department, Fresenius Medical Care, Istanbul, Turkey

Search for more papers by this author
Stefano Stuard

Stefano Stuard

Fresenius Medical Care Europe, Clinical and Therapeutical Governance, Bad Homburg v.d.H., Germany

Search for more papers by this author
Kıvanc Yuksel

Kıvanc Yuksel

Department of Data Management and Biostatistics, Ege University, ARGEFAR, Izmir, Turkey

Search for more papers by this author
Ercan Ok

Ercan Ok

Division of Nephrology, Ege University School of Medicine, Izmir, Turkey

Search for more papers by this author
Gulay Asci

Corresponding Author

Gulay Asci

Division of Nephrology, Ege University School of Medicine, Izmir, Turkey

Correspondence to: Gulay Asci, Department of Nephrology, Ege University School of Medicine, 35100, Bornova, Izmir, Turkey. E-mail: [email protected]; [email protected]

Search for more papers by this author
First published: 12 March 2019
Citations: 4
Conflict of Interest: E.O. is a member of the scientific advisory board in Fresenius Medical Care. F.K. and S.S. are employees of Fresenius Medical Care. M.E., N.W.L., A.C., K.Y., and G.A. declare no conflict of interest.

Abstract

Introduction: Numerous studies showed that higher body mass index (BMI) is associated with better survival in hemodialysis (HD) patients. Most of them evaluated short-term mortality. It has been suggested that presence of inflammation may be a key modifier of relationship between BMI and mortality in incident HD patients. We examined whether presence of inflammation modifies the association between BMI and mortality in both short-term and long-term follow-up in a large group of prevalent HD patients.

Methods: A total of 3.252 HD patients from 41 HD centers were enrolled; the patients were divided into quartiles based on time-averaged BMI (Q1 < 21.5, Q2 21.5 to <24.3, Q3 24.3 to <27.4, Q4 ≥ 27.4 kg/m2). Inflammation status was defined as present (inflamed) (C-reactive protein (CRP) ≥1.0 mg/dL and/or serum albumin ≤3.5 g/dL) or absent (noninflamed).

Findings: During 7 years of follow-up 1386 patients (42.6%) died. Compared to noninflamed patients, inflamed patients in the lowest BMI quartile showed 5-fold increased risk for mortality in the short-term (95% confidence interval [CI] 2.82–9.22, P < 0.001) and 3-fold in the long-term (95%CI 2.42–4.27, P < 0.001) compared to the highest BMI quartile. Whereas, inflamed patients in the highest BMI quartile experienced 2-fold increased risk in short-term (95%CI 1.17–3.74, P = 0.01) and 1.68-fold increased risk in long-term (95%CI 1.30–2.18, P < 0.001) than in noninflamed patients. The protective effect of BMI for overall mortality was present in all age groups, in both genders, in patient with and without diabetes. BMI was not a mortality predictor in patients with HD duration more than 76 months at baseline. The protective effect of BMI was observed in all albumin tertiles. In patients in the lowest CRP tertile, BMI was not associated with mortality.

Discussion: Higher BMI is associated with lower short-term and long-term mortality risk, especially in patients with inflammation in a prevalent HD population.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.